The cephalosporin antimicrobial agents: a comprehensive review (Q39645676)

13 September 2017

1 reference

title

The cephalosporin antimicrobial agents: a comprehensive review (English)

1 reference

13 September 2017

Caprile KA

1

1 reference

13 September 2017

1 March 1988

1 reference

Journal of Veterinary Pharmacology and Therapeutics

13 September 2017

1 reference

13 September 2017

11

1 reference

13 September 2017

1

1 reference

13 September 2017

1-32

1 reference

The Ecology of Transferable Drug Resistance in the Enterobacteria

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Cefotetan: profile of in-vitro activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Penicillin allergy and the cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Pasteurella multocida. Infections after domestic animal bites and scratches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Hemolytic Anemia Associated With Cephalothin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Resistance to cephalosporins among gentamicin-resistant klebsiellae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

The barrier function of the gram-negative envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Nephrotoxicity of cephalosporin-gentamicin combinations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

The new beta-lactamase-stable cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Description and classification of the newer cephalosporins and their relationships with the established compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Discovery and development of Moxalactam (6059-S): the chemistry and biology of 1-oxacephems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Factors influencing the antibacterial action of -lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Prophylactic and Preventive Antibiotic Therapy Timing, Duration and Economics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

The effect of renal cation transport inhibition on cephaloridine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

Experimental ampicillin glomerulonephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1988.TB00117.X

10.1111/J.1365-2885.1988.TB00117.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

3288766